ADVANCED NSCLC
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Must be experienced in managing NSCLC patients specializing in oncology, radiation oncology or thoracic surgery (qualified attending/vice chief/chief physician who has at least 2 years of experiences in managing patients with advanced NSCLC) 2) Experienced of immunotherapy of 1L mNSCLC patients: • For participants from Tier 1-2 city, treatment of at least 5 patients with 1L anti-PD-1/L1 inhibitors in past 3 months is required • For participants from Tier 3-5 city, 1L IO treatment of mNSCLC patients in past 6 months is required 3) At least 60% of the time spent in direct patient care
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment patterns and most common 1L utilization of IO in advanced NSCLC patients in China; | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify key factors of decision making of real-world clinical practice of 1L IO treatment in NSCLC patients, from Chinese doctors with different department; | — |
Countries
China
Contacts
Shanghai Geriatric Medical Center